Clinically : Actualité Clinically en direct - P1 | Bourse Reflex
Accueil > Tags > Clinically

  • Toutes les actualités en rapport avec « Clinically »

08/11 18:00 Clinically - 2016 3rd quarter results on track with the Bright2020 strategic plan roadmap

13/09 18:15 Clinically - Good operating performances and financial discipline in executing the 2016 action plans

29/07 18:00 Clinically - A good first half: 5.3% in organic growth

13/06 18:35 Clinically - GENTICEL ANNOUNCES COMPLETION OF TWO MAJOR MILESTONES IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

10/05 18:00 Clinically - Year off to a good start: Organic growth of 6.3% (constant currency and structure)

04/02 18:00 Clinically - Strong rebound in growth for 2015: +21.5%

30/11 18:00 Clinically - Sharp improvement in the operating profitability for Q3 2015

04/11 18:00 Clinically - Continuing growth in the Q3 2015

29/07 18:00 Clinically - Strong H1 2015 growth: +28.3%

28/04 18:00 Clinically - Very robust first-quarter growth: +23.9% (current exchange rates)

19/10 16:35 Clinically - Apricus Biosciences Announces Issuance of Korean Patent, Expanding Its Patent Portfolio for Its Topical Cream to Treat Premature Ejaculation

14/10 08:30 Clinically - Apricus Biosciences Announces New Data Published in the International Journal of Pharmaceutics Confirming Efficiency of NexACT(R) Drug Delivery Technology

06/10 16:05 Clinically - Apricus Biosciences to Present Poster of Femprox(R) Phase III Clinical Data at Upcoming Industry Conference

03/10 20:05 Clinically - Apricus Biosciences Announces Korean Patent Approval for MycoVa(TM) for Nail Fungus

22/09 15:00 Clinically - StemCells, Inc. Announces World's First Neural Stem Cell Transplant in Spinal Cord Injury Patient

12/09 08:15 Clinically - Apricus Biosciences to Provide Overview of Rx and Consumer Healthcare Divisions at the 11th Annual Biotech in Europe Investor Forum

31/08 16:20 Clinically - Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

18/08 15:00 Clinically - Photo Release -- Apricus Biosciences Announces FDA Clearance for Its First Anti-Fungal OTC Drug (Tolnaftate-D(TM)) Containing NexACT(R) Technology

12/08 09:00 Clinically - Apricus Biosciences Announces Second Quarter 2011 Financial Results Conference Call

08/08 16:05 Clinically - Apricus Biosciences to File for Market Authorization to Sell Vitaros(R) for Erectile Dysfunction in Latin America